|
|
Volumn 47, Issue 6, 2012, Pages 465-470
|
|
Monitoring patients on anti-malarials: where are we now?;Le suividespatientsensoins antipaludéens :Où en sommes-nous ?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHLOROQUINE;
HYDROXYCHLOROQUINE;
ANTIMALARIAL AGENT;
BODY WEIGHT;
DISEASE ASSOCIATION;
DRUG MONITORING;
EYE EXAMINATION;
EYE TOXICITY;
HUMAN;
PATIENT MONITORING;
RETINA MACULOPATHY;
REVIEW;
VISUAL ACUITY;
ARTHRITIS;
BODY CONSTITUTION;
CHEMICALLY INDUCED DISORDER;
COLOR VISION DEFECT;
DRUG EFFECT;
EDITORIAL;
ELECTRORETINOGRAPHY;
FEMALE;
FLUORESCENCE ANGIOGRAPHY;
MIDDLE AGED;
OPHTHALMOLOGY;
OPTICAL COHERENCE TOMOGRAPHY;
ORGANIZATION;
PRACTICE GUIDELINE;
RETINA;
SCOTOMA;
STANDARD;
UNITED STATES;
VISUAL FIELD;
ACADEMIES AND INSTITUTES;
ANTIMALARIALS;
ARTHRITIS;
BODY CONSTITUTION;
COLOR VISION DEFECTS;
DRUG MONITORING;
ELECTRORETINOGRAPHY;
FEMALE;
FLUORESCEIN ANGIOGRAPHY;
HUMANS;
HYDROXYCHLOROQUINE;
MIDDLE AGED;
OPHTHALMOLOGY;
PRACTICE GUIDELINES AS TOPIC;
RETINA;
SCOTOMA;
TOMOGRAPHY, OPTICAL COHERENCE;
UNITED STATES;
VISUAL FIELDS;
|
|
EID: 84875432212
PISSN: 00084182
EISSN: 17153360
Source Type: Journal
DOI: 10.1016/j.jcjo.2012.09.006 Document Type: Editorial |
|
Times cited : (9)
|
|
References (5)
|
